Agilent receives FDA approval for PD‑L1 IHC 22C3 pharmDx in esophageal and GEJ carcinoma
Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA (pembrolizumab)
Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA (pembrolizumab)
Elecsys pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology
Researchers harness next-generation detectors to capture magnetic dynamics in microseconds
Conference tackles regulatory alignment, digital twins and omics data
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system
Cast your vote in the 2026 Scientists' Choice Awards for the product that has made the most difference to your lab
New MDx‑Chex for RLP controls support full‑process verification for respiratory molecular assays
Presentations on Open Aperture, Apertura's material transfer agreement program, describe how open academic access to TfR1 CapX can unlock innovation and collaboration across the field
New PTC Harmony thermal cycler line expands access to reliable, high‑performance PCR across academic and biopharma laboratories
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
A study led by Karl Landsteiner University shows that the disease affects whole-brain communication networks, and that this may help predict survival
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1
Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Vote for the products that have made the most difference to your research for the chance to win a $100 Amazon Gift Card (or equivalent currency)
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets
Expanded CFTR variant coverage designed to align with updated professional recommendations
After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories
Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck
Discover how BRANDTECH’s latest pipette allows temporary fine-tuning for different liquids, temperatures, and tip styles